BIOMAT Database Logo BIOMAT Database Logo

Is death inevitable with multiresistant TB plus HIV infection? 1997

F Drobniewski
PHLS Mycobacterium Reference Unit, King's College School of Medicine, Londor, UK.

UI MeSH Term Description Entries
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018088 Tuberculosis, Multidrug-Resistant Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS. Tuberculosis, Drug-Resistant,Tuberculosis, MDR,Tuberculosis, Multi-Drug Resistant,Drug-Resistant Tuberculosis,MDR Tuberculosis,Multi-Drug Resistant Tuberculosis,Multidrug-Resistant Tuberculosis,Tuberculosis, Drug Resistant,Tuberculosis, Multi Drug Resistant,Tuberculosis, Multidrug Resistant

Related Publications

F Drobniewski
[Is death biologically inevitable?].
January 2003, Duodecim; laaketieteellinen aikakauskirja,
F Drobniewski
TB plus HIV spells trouble.
May 1992, The American journal of nursing,
F Drobniewski
When imminent death is inevitable.
August 1983, MLO: medical laboratory observer,
F Drobniewski
Chronic uremia: is death inevitable?
May 1970, Hospital management,
F Drobniewski
TB or not TB in HIV infection.
January 2016, Pneumologia (Bucharest, Romania),
F Drobniewski
Inevitable death.
January 1994, The Hastings Center report,
F Drobniewski
Dual epidemic is developing in Russia. Co-infection (HIV / TB).
September 2000, AIDS weekly,
F Drobniewski
[Inevitable senile death].
January 2014, Duodecim; laaketieteellinen aikakauskirja,
F Drobniewski
Is Aging as Inevitable as Death and Taxes?
June 2016, Cell metabolism,
F Drobniewski
Co-infection with HIV and TB: double trouble.
February 2005, International journal of STD & AIDS,
Copied contents to your clipboard!